Board of Directors

Don Spence retired in August 2019 as President and Chief Executive Officer of Ebb Therapeutics, a company in the business of developing and marketing medical products for the treatment of insomnia, a position he held since March 2017. Prior to joining Ebb Therapeutics, Mr. Spence served as Chairman and Chief Executive Officer of Lake Region Medical, Inc. from 2010 until its acquisition by Integer Holdings Corporation in October of 2015. From 2005 to 2008, he served as President of the Sleep and Home Respiratory Group for Philips Respironics, and from 2008 to 2010 as Chief Executive Officer of Philips Home Healthcare Solutions. Prior to that, Mr. Spence spent eight years with GKN Sinter Metals, as Senior Vice President for Global Sales and Marketing from 1998 to 2001 and as President from 2001 to 2005. Prior to 1998, he served in a number of roles at BOC Group, PLC over a 15-year career at that company including President, Ohmeda Medical Systems from 1997 to 1998. Mr. Spence serves on the boards of the following publicly held companies: Integer Holdings Corp and Vapotherm, Inc., both medical device manufacturers. Mr. Spence also serves on the board of Linguaflex, Inc. Mr. Spence earned his B.A. in Economics from Michigan State University and his M.A. in Economics from Central Michigan University.

Dr. Trit Garg currently serves as a Vice President at Patient Square Capital, a health care focused investment firm. Prior to joining Patient Square, Dr. Garg was a Principal at HealthQuest Capital. Previously Dr. Garg was a resident physician in Internal Medicine at Stanford University Hospital. Earlier during his medical training, Dr. Garg spent time at KKR, a private equity firm, and McKinsey & Company.

Dr. Garg currently serves on the Board of Directors of Access TeleCare.

Dr. Garg holds an M.D. from Stanford Medical School and an M.B.A. from Stanford’s Graduate School of Business. He graduated with a B.A. with High Distinction from the University of California, Berkeley, where he was a Regents’ and Chancellor’s Scholar.

Karr Narula is a Founding Partner of Patient Square Capital, a health care focused investment firm. He has over 18 years of health care investment and operations experience. At Patient Square, Mr. Narula brings an operational lens to health care investment decisions and oversees the firm's Transformation and Growth (TAG) Team, which deploys specialized transformation and growth capabilities to unlock value within portfolio companies. He currently serves on the Board of Directors of Access Telecare.

Prior to Patient Square, Mr. Narula spent 13 years at KKR, a private equity firm, where he was a Partner and Head of KKR's Portfolio Operations Team (KKR Capstone) in the Americas. In this role, he led the team responsible for value creation across all industries and asset classes in the Americas and directly drove value creation efforts within the health care sector. While at KKR, Mr. Narula was a member of KKR's Americas Private Equity Portfolio Management Committee, KKR's Health Care Strategic Growth Portfolio Management Committee, and KKR's Portfolio Operations Global Operating Committee.

Mr. Narula has extensive experience using technology, process and organization to strengthen and transform health care companies. During his tenure at KKR, he worked closely with health care portfolio companies across subsectors and stages of growth including Biomet, Harden Healthcare, Research Pharmaceutical Services, Air Medical Group Holdings, Amedisys, PRA Health Sciences, Panasonic Healthcare, Bayer Diabetes Care, Blue Sprig Pediatrics, Covenant Physician Partners, PharMerica, Brightspring Health Services, Envision Healthcare, and American Medical Response.

Additionally, he has served on the Boards of Directors of Blue Sprig Pediatrics and Access Physicians. Prior to joining KKR in 2007, he was a private equity investor at HIG Capital and before that, a consultant at Bain & Company in San Francisco and in London.

Mr. Narula holds a B.S. in Industrial Engineering with Distinction from Stanford University and an M.B.A. from Harvard Business School.

Justin Sabet-Peyman currently serves as a Managing Director of Patient Square Capital, a health care focused investment firm. Mr. Sabet-Peyman previously worked at KKR on the Americas Health Care Team for over 10 years where he focused on private equity and growth equity investing. Mr. Sabet-Peyman also spent a year helping to build the Direct Investments platform at Mubadala Investment Company, and he started his career at McKinsey & Company where he served corporate and private equity clients.

Mr. Sabet-Peyman currently serves on the Board of Directors of Access Telecare and previously served on the Boards of Heartland Dental, PetVet Care Centers, Trilogy MedWaste, Ebb Therapeutics, EchoNous, Arbor Pharmaceuticals, and Lake Region Medical.

Mr. Sabet-Peyman received his B.S. and M.S. in Electrical Engineering from Stanford University where he graduated as the Henry Ford II Scholar and was a Mayfield Fellow.